Question 1

What specific symptoms or conditions make me eligible for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease clinical trial (NCT05197049). Contact the study team or your healthcare provider for specific answers.

Question 2

How does guselkumab compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease clinical trial (NCT05197049). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of guselkumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease clinical trial (NCT05197049). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease clinical trial (NCT05197049). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the treatment process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease clinical trial (NCT05197049). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease clinical trial (NCT05197049). Contact the study team or your healthcare provider for specific answers.

What this study is about